Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VICTORY
jRCTs051180156Completed
- Sponsor
- Not applicable
- Start
- Feb 2018
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Randomised trial in secondary hyperparathyroidism (SHPT) comparing Etelcalcetide arm with Maxacalcitol arm (2 arms). Primary endpoint: Change in T50 at 12 months from baseline. Started Feb 2018; status: completed.
02
Drugs
etelcalcetidemaxacalcitol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on jRCTs051180156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180156.